• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Predictors of edge stenosis after paclitaxel-eluting stent implantation.

作者信息

Kang Woong Chol, Park Yae Min, Shin Kwen-Chul, Moon Chan Il, Shin Mi Seung, Lee Kyounghoon, Han Seung Hwan, Ahn Taehoon, Shin Eak Kyun

机构信息

Department of Cardiology, Gil Hospital, Gachon University of Medicine and Science, Namdong-gu, Incheon, Republic of Korea.

出版信息

Coron Artery Dis. 2011 Mar;22(1):59-63. doi: 10.1097/MCA.0b013e328343fbff.

DOI:10.1097/MCA.0b013e328343fbff
PMID:21285877
Abstract

BACKGROUND

Although edge stenosis (ES) is a main limitation of drug-eluting stents, the predictors for ES are not well known. We evaluated the predictors for ES after paclitaxel-eluting stent implantation.

METHODS

One hundred and eleven angina patients (64 men; 62.2±8.4 years of age) were divided into ES (n=9) and non-ES groups (n=102). The clinical findings, procedural factors, and intravascular ultrasound (IVUS) parameters were analyzed.

RESULTS

Although clinical characteristics were not different between groups, diabetes mellitus (DM) was more common in the ES group (P=0.002). The vessel, plaque, and lumen areas of the lesions were not different between groups; however, the vessel area of the proximal and distal reference artery was smaller in the ES group. Lesions with positive remodeling were more common in the ES group (P=0.015). On the basis of univariate analysis, predictors of ES included DM, lesions with positive remodeling, IVUS parameters, and procedural factors. After adjusting for clinical findings, angiographic factors, and IVUS parameters, the presence of DM [odds ratio (OR): 9.20; 95% confidence interval (CI): 1.40-60.62, P=0.021] and lesions with positive remodeling (OR: 5.93; 95% CI: 1.13-31.02, P=0.035) were independent predictors of ES. The lumen area in the distal 1 mm reference segment was a protective factor for ES (OR: 0.05; 95% CI: 0.00-0.74, P=0.029).

CONCLUSION

The risk of ES after paclitaxel-eluting stent implantation was higher in patients who had DM and lesions with positive remodeling. Of the IVUS parameters, the lumen area in the distal 1 mm reference segment was a protective factor against ES.

摘要

相似文献

1
Predictors of edge stenosis after paclitaxel-eluting stent implantation.
Coron Artery Dis. 2011 Mar;22(1):59-63. doi: 10.1097/MCA.0b013e328343fbff.
2
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.紫杉醇洗脱支架置入术后最小支架面积对 9 个月随访通畅率的影响:来自 TAXUS IV、V、VI 及 TAXUS ATLAS Workhorse、长病变、直接支架试验的血管内超声综合分析。
JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.
3
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial.糖尿病患者中依维莫司洗脱支架与紫杉醇洗脱支架置入的随机比较:DES-DIABETES(糖尿病患者药物洗脱支架)试验的 4 年临床结果。
JACC Cardiovasc Interv. 2011 Mar;4(3):310-6. doi: 10.1016/j.jcin.2010.12.006.
4
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.用于治疗冠状动脉开口病变的药物洗脱支架:西罗莫司洗脱支架与紫杉醇洗脱支架的比较
Coron Artery Dis. 2008 Nov;19(7):507-11. doi: 10.1097/MCA.0b013e32830936d4.
5
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.紫杉醇洗脱球囊血管成形术和钴铬支架与传统血管成形术和紫杉醇洗脱支架治疗糖尿病患者的原发性冠状动脉狭窄。
EuroIntervention. 2011 May;7 Suppl K:K83-92. doi: 10.4244/EIJV7SKA15.
6
Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.糖尿病对药物洗脱支架时代血管反应的影响:荟萃容积血管内超声分析。
Circ Cardiovasc Interv. 2012 Dec;5(6):763-71. doi: 10.1161/CIRCINTERVENTIONS.111.962878. Epub 2012 Nov 13.
7
Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial.紫杉醇和西罗莫司洗脱支架后高压球囊扩张后的血管造影和血管内超声随访:来自支架后最佳支架扩张试验。
Catheter Cardiovasc Interv. 2011 Jan 1;77(1):15-21. doi: 10.1002/ccd.22635. Epub 2010 Oct 6.
8
Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients.
EuroIntervention. 2009 Aug;5(3):349-54. doi: 10.4244/v5i3a55.
9
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响:来自 SPIRIT(依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估)和 COMPARE(真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架)随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.
10
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.ENDEAVOR IV 试验中糖尿病患者的临床和血管造影结果:冠状动脉疾病患者中使用佐他莫司和紫杉醇洗脱支架的随机比较。
JACC Cardiovasc Interv. 2009 Oct;2(10):967-76. doi: 10.1016/j.jcin.2009.08.008.